Atlas Trials

Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma

Clinical trial NCT01045928 · TERMINATED

Trial details

NCT number
NCT01045928
Sponsor
Case Comprehensive Cancer Center
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Adult Non-Hodgkin LymphomaAdult Grade III Lymphomatoid GranulomatosisContiguous Stage II Adult Burkitt LymphomaContiguous Stage II Adult Diffuse Large Cell LymphomaContiguous Stage II Adult Diffuse Mixed Cell LymphomaContiguous Stage II Adult Diffuse Small Cleaved Cell LymphomaContiguous Stage II Adult Immunoblastic Large Cell LymphomaContiguous Stage II Adult Lymphoblastic LymphomaContiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular LymphomaContiguous Stage II Grade 3 Follicular LymphomaContiguous Stage II Mantle Cell Lymphoma
Start date
2010-01-01
Primary completion
2011-03-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.